Clinical Trial Update: Finger Hardness Measure in Scleroderma

View source ↗

Summary

A Mayo Clinic-sponsored trial assessing finger hardness as a biomarker in systemic sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Mayo Clinic | Conditions: Scleroderma | Status: COMPLETED